Treatment of avascular or hypovascular micro-tumors
Abstract:
The invention relates to vascular disrupting agent (VDA) such as combretastatins for treating avascular or hypovascular micro-tumors with a diameter below 20 mm.
Information query
Patent Agency Ranking
0/0